2-(4-Bromo-5-nitro-1H-pyrazol-1-yl)ethanol, 95.0%, 1g

Dehydroacetic Acid>98.0%(GC)(T)25g

Ethyl 2-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)acetate, 95.0%, 1g

2-Acetamido-5-fluorobenzoic acid, 98.0%, 5g

1-(2,5-Dimethoxy-benzenesulfonyl)-piperazine, 1g

L-Methionine, N-[(1,1-dimethylethoxy)carbonyl]-, compd. withN-cyclohexylcyclohexanamine (1:1), 97%, 10g

5-Bromo-2-(chloromethyl)pyridine hydrochloride, 95.0%, 10g

(S)-Butyl 2-aminopropanoate, 95.0%, 250mg

((3aR,5R,6R,6aR)-6-Hydroxy-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl)methyl benzoate, 98%, 100mg

6,6-Dimethylpiperazin-2-one, 98+%, 500mg

Methyl 3-amino-5-hydroxybenzoate, 95.0%, 250mg

2-((Tetrahydro-2H-pyran-4-yl)oxy)acetic acid, 97%, 1g

1-Methyl-1H-pyrazole-4,5-diamine bis(sulfate), 100mg